1[1]Brossart P,Wirths S,Brugger W,et al.Dendritic cells in cancer vaccines.Exp Hematol,2001,29:1247-1255.
2[2]Brossart P,Wirths S,Stuhler G,et al.Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells.Blood,2000,96:3102-3108.
3[3]Santin AD,Bellone S,Ravaggi A,et al.Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells.Obstet Gynecol,2000,96:422-430.
4[4]Kim DK,Kim JH,Kim YT,et al.The comparison of cytotoxic T-lymphocyte effects of dendritic cells stimulated by the folate binding protein peptide cultured with IL-15 and IL-2 in solid tumor.Yonsei Med J,2002,43:691-700.
5[5]Hernando JJ,Park TW,Kubler K,et al.Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies:clinical and immunological evaluation of a phase I trial.Cancer Immunol Immunother,2002,51:45-52.
6[6]Santin AD,Hermonat PL,Ravaggi A,et al.In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.Am J Obstet Gynecol,2000,183:601-609.
7[7]Santin AD,Bellone S,Palmieri M,et al.Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer.Int J Gynecol Cancer,2004,14:64-75.
8[8]Schlienger K,Chu CS,Woo EY,et al.Trance-and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.Clin Cancer Res,2003,9:1517-1527.
10[11]Gong J,Chen D,Kashiwaba M,et al.Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells.Proc Natl Acad Sci USA,1998,95:6279-6283.
2Juan Zhang~1 Jin-Kun Zhang~2 Shao-Hong Zhuo~3 Hai-Bin Chen~2 1 Clinical Laboratory,The First Affiliated Hospital of Shantou University Medical College,Shantou 515041,Guangdong Province,China2 Cancer Pathology Laboratory,Shantou University Medical College,Shantou 515031,Guangdong Province,China3 Department of Gastroenterology,Third Municipal Hospital of Shantou,Shantou 515073,Guangdong Province,China.Effect of a cancer vaccine prepared by fusions of hepatocarcinoma cells with dendritic cells[J].World Journal of Gastroenterology,2001,7(5):690-694. 被引量：26
4Gong J,Nikrui N,Chen D,et al.Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity[J].J Immunol,2000,165:1705-1711.
5Mayordomo J,Zorina T,Storkus W,et al.Bone marrow-derived dendritic cells pulsed with synthetic tumor peptide elicit protective and therapeutic antitumor immunity[J].Nature Med,1995,1:1297-1302.
6Wang J,Saffold S,Cao X,et al.Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines[J].J Immunol,1998,161:5516-5524.
7Koido S,Ohana M,Liu C,et al.Dendritic cells fused with human cancer cells:morphology,antigen expression,and T cell stimulation[J].Clin Immunol,2004,113:261-269.
8Cerundolo V,Hermans IF,Salio M.Dendritic cells:a journey from laboratory to clinic[J].Nat Immunol,2004,5:7-10.
9Cao MD,Chen ZD,Xing Y.Gamma irradiation of human dendritic cells influences proliferation and cytokine profile of T cells in autologous mixed lymphocyte reaction[J].Cell Biol Int,2004,28:223-228.
10Tai KF,Chen DS,Hwang LH.Curative potential of GM-CSF-secreting tumor cell vaccines on established orthotopic liver tumors: mechanisms for the superior antitumor activity of live tumor cell vaccines[J].J Biomed Sci,2004,11:228-238.
